GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Cyclically Adjusted Revenue per Share

Star Lake Bioscience Co (SHSE:600866) Cyclically Adjusted Revenue per Share : ¥5.06 (As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Star Lake Bioscience Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥2.431. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥5.06 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Star Lake Bioscience Co's average Cyclically Adjusted Revenue Growth Rate was 20.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 36.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 25.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Star Lake Bioscience Co was 36.80% per year. The lowest was -6.20% per year. And the median was 5.40% per year.

As of today (2025-07-01), Star Lake Bioscience Co's current stock price is ¥7.02. Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥5.06. Star Lake Bioscience Co's Cyclically Adjusted PS Ratio of today is 1.39.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Star Lake Bioscience Co was 4.48. The lowest was 0.96. And the median was 2.44.


Star Lake Bioscience Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Cyclically Adjusted Revenue per Share Chart

Star Lake Bioscience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.66 1.89 3.16 3.98 4.84

Star Lake Bioscience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 4.41 4.66 4.84 5.06

Competitive Comparison of Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Star Lake Bioscience Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Cyclically Adjusted PS Ratio falls into.


;
;

Star Lake Bioscience Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Star Lake Bioscience Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.431/115.1156*115.1156
=2.431

Current CPI (Mar. 2025) = 115.1156.

Star Lake Bioscience Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.318 99.500 0.368
201509 0.266 100.500 0.305
201512 0.189 100.600 0.216
201603 0.240 102.200 0.270
201606 0.263 101.400 0.299
201609 0.261 102.400 0.293
201612 0.378 102.600 0.424
201703 0.175 103.200 0.195
201706 0.257 103.100 0.287
201709 0.314 104.100 0.347
201712 0.345 104.500 0.380
201803 0.359 105.300 0.392
201806 0.330 104.900 0.362
201809 0.309 106.600 0.334
201812 0.452 106.500 0.489
201903 0.426 107.700 0.455
201906 0.329 107.700 0.352
201909 0.393 109.800 0.412
201912 0.265 111.200 0.274
202003 0.388 112.300 0.398
202006 0.404 110.400 0.421
202009 0.299 111.700 0.308
202012 0.420 111.500 0.434
202103 0.411 112.662 0.420
202106 0.398 111.769 0.410
202109 0.354 112.215 0.363
202112 3.179 113.108 3.235
202203 3.643 114.335 3.668
202206 4.064 114.558 4.084
202209 3.539 115.339 3.532
202212 3.504 115.116 3.504
202303 2.504 115.116 2.504
202306 2.470 114.558 2.482
202309 2.688 115.339 2.683
202312 2.793 114.781 2.801
202403 2.528 115.227 2.526
202406 2.580 114.781 2.588
202409 2.589 115.785 2.574
202412 2.736 114.893 2.741
202503 2.431 115.116 2.431

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Star Lake Bioscience Co  (SHSE:600866) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Star Lake Bioscience Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.02/5.06
=1.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Star Lake Bioscience Co was 4.48. The lowest was 0.96. And the median was 2.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Star Lake Bioscience Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Executives
Chen Wu Director
Liu Xian Yi Director
Liao Jie Ming senior management
Chen Chao Ju Director
Li Qing Lin Supervisors
Zhong Zi Rong Director

Star Lake Bioscience Co Headlines

No Headlines